Analyst Reco. Lavipharm S.A.

Equities

Market Closed - Athens S.E. Other stock markets 10:19:23 2024-05-14 am EDT			5-day change	1st Jan Change
0.895 ^EUR	+0.56%		+5.54%	+12.44%

Feb. 28	Lavipharm S.A. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	Lavipharm S.A. entered into a new asset purchase agreement to acquire Flagyl product line for Greek market from Sanofi.	CI

No results for this search